Ушбу ишга иқтибос қилган ишлар

3 та иш

Иш: Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

1. MO638: Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Obesity, Type Two Diabetes, CKD

   Sherzod Abdullaev, Ranokhon Igamberdieva

   МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 иқтибос

   ABIABI:AkademIndex/openalex/2022.article.004913

2. Advancements in risk stratification and management strategies in primary cardiovascular prevention

   Fotios Barkas, Yusuf Ziya Şener, Pelin Golforoush +25

   Шарҳ мақолаLipoproteins and Cardiovascular HealthAtherosclerosis20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.review-article.000004

3. Peptide drugs for obesity and type 2 diabetes mellitus: an overview of clinical trials

   Haniyeh Barzgar, Darmadi Darmadi, Jabbarova Nafisa +2

   Шарҳ мақолаDiabetes Treatment and ManagementClinica Chimica Acta20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.review-article.000250